The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
A.J. Gelderblom, MD, PhD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Michiel van de Sande, MD, PhD
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Chelsea Cole, MD
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
All Sides of the Joint: Integrated TGCT Care Across Specialties
From Data to Debate: Global Perspectives on HR+/HER2- mBC Care
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Komal Jhaveri, MD, FACP
Hiraji Iwata, MD, PhD
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
Spotlight on Europe: Adapting the Evidence
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
Joyce F. Liu, MD, MPH
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
Kathleen Moore, MD, MS
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
Lauren A. Byers, MD
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC
Luis Paz-Ares, MD, PhD
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.